Jump to page content

Search results

  • Sponsors

    Sponsors of the BIH Charité Clinician Scientist Programs The BIH Charité Clinician Scientist Program (CSP) is core-funded by the BIH and Charité . However, despite the great success of the program and the basic funding, the BIH Charité CSP is dependent on additional financial support from external donors. The BIH Charité Clinician Scientist Program…

  • Co-innovation program Enterprise Singapore

    Co-innovation programme between Enterprise Singapore and Charite/BIH In November 2023, the signing of a Memorandum of Understanding (MoU) between Charité - Universitätsmedizin Berlin, the Berlin Institute of Health (BIH) and Enterprise Singapore for a co-innovation program laid the foundation for a professional network of start-ups from Singapore…

  • News Charité BIH Innovation

    EXIST Transfer of Research program gives go-ahead for BoneGuide

    The BoneGuide team is one step closer to making its transformative bone healing technology available to healthcare providers and patients alike. BoneGuide is a project of Charité - Universitätsmedizin Berlin and is supported by Charité BIH Innovation. On May 1, 2024, Aaron Herrera and his team officially entered the first phase of the EXIST…

  • News BIH Academy

    BIH Charité AdCSP successfully evaluated

    On April 9, 2024, the BIH Charité Advanced Clinician Scientist Pilot Program (AdCSP) was successfully evaluated by a top-class external panel of experts and can now enter the second funding phase of three years.

  • News Charité BIH Innovation

    Start-ups from Singapore looking for project partners at Charité

    Charité/BIH and Enterprise Singapore (ESG) have established an innovation support program that promotes cooperation between excellent clinicians from Charité/BIH and start-ups from Singapore. Following the successful application of start-ups from Singapore, we are now looking for project partners at Charité/BIH.

  • Program and call for proposals

    Program and call for proposals The aim of the current call (start 01.03.2024) at Enterprise Singapore is to shape our partnership through transnational project work. New technologies and medical innovations from Singapore companies are to be further developed together with Charité and BIH researchers so that they can be made available to patients…

  • Background

    Background In November 2023, a Memorandum of Understanding was signed between Charité-Universitätsmedizin Berlin, the Berlin Institute of Health Sciences and Enterprise Singapore, the Singapore government agency championing enterprise development, with the aim of strengthening international collaboration and translational research. Building on this…

  • Agenda

    Agenda Table Process stage Deadline Publication of the call 01.03.2024 Startups submit Expression of Interest (EoI) to Enterprise Singapore April 2024 First phase: Startups and Charité/BIH employees are "matched", (Letter of Intent, LoI from Charité/BIH employees), shortlist of selected startups for second phase is submitted to ES May 2024 Second…